CARLSBAD, Calif., Sept. 18, 2019 /PRNewswire/ -- ChromaCode, Inc., a next-generation molecular diagnostics company using data science to significantly enhance multiplexing capabilities of life science instrumentation, today announced publication of a study by the Medical College of Wisconsin, Milwaukee Wisconsin

LEXINGTON, Mass., Sept. 18, 2019 /PRNewswire/ -- Bladder cancer is the fifth most common cancer in industrialized countries, affecting roughly 2.7 million people worldwide. Muscle-invasive bladder cancer (MIBC), an aggressive and potentially lethal form of the disease, affects between 20 and 25 percent of patients diagnosed each year.

SHANGHAI, Sept. 18, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, received the Asia-Pacific Medical Imaging Visionary Innovation Leadership Award at the Frost & Sullivan Asia-Pacific Best Practices Awards Banquet recently.Held annually in Singapore by Frost & Su

GREENSBORO, N.C., Sept. 18, 2019 /PRNewswire/ -- Piedmont Animal Health Inc., which specializes in developing novel medications that improve compliance and ease of use, tod

ALISO VIEJO, Calif., Sept. 18, 2019 /PRNewswire/ -- At the annual OR Manager Conference in New Orleans this week, Randy Saad, director of Perioperative Services at

LONDON and CHICAGO, Sept. 18, 2019 /PRNewswire/ -- NHS Wales has selected RLDatix, the leading global provider of intelligent patient safety solutions, to implement a comprehensive risk and compliance management solution for its Once for Wales Concerns Management System, that will standardise patient safety approaches and share criti

PORTLAND, Ore., Sept. 18, 2019 /PRNewswire/ -- ORM Fertility is celebrating 30 years of excellence in reproductive medicine. On Saturday, Sept. 7, more

NEW HAVEN, Conn., Sept. 18, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company"), a clinical stage biopharmaceutical company with a portfolio of late-stage product candidates for neurological and neuropsychiatric diseases, announced today that the Company's myeloperoxidase (MPO) inhibitor, verdiperstat, has been sel

MIAMI and TOKYO, Sept. 18, 2019 /PRNewswire/ -- Santen Pharmaceutical Co., Ltd., the leader in ophthalmic drug development, has selected ArisGlobal to create a single global safety database and improve the efficiency and quality of their global safety vigilance

TUCSON, Ariz., Sept. 18, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the release of positive results from three clinical studies on the Accelerate Pheno™ system that will be presented at IDWeek™ 2019.